Investigational Drug Information for L-Leucovorin
✉ Email this page to a colleague
What is the development status for investigational drug L-Leucovorin?
L-Leucovorin is an investigational drug.
There have been 25 clinical trials for L-Leucovorin.
The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 1997.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Autistic Disorder, and Adenocarcinoma. The leading clinical trial sponsors are Gruppo Oncologico del Nord-Ovest, Pfizer, and Hokkaido Gastrointestinal Cancer Study Group.
Summary for L-Leucovorin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,490 |
| WIPO Patent Applications | 979 |
| Japanese Patent Applications | 306 |
| Clinical Trial Progress | Phase 3 (1997-10-01) |
| Vendors | 26 |
Recent Clinical Trials for L-Leucovorin
| Title | Sponsor | Phase |
|---|---|---|
| Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | Foundation Medicine | Phase 2 |
| Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | Servier | Phase 2 |
| Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | Gruppo Oncologico del Nord-Ovest | Phase 2 |
Clinical Trial Summary for L-Leucovorin
Top disease conditions for L-Leucovorin
Top clinical trial sponsors for L-Leucovorin
US Patents for L-Leucovorin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
